The pharmaceutical sector, being a highly research-oriented and data-driven industry, constantly leverages analysis of empirical data to trigger innovations. However, the volume of data has increased dramatically over the years. With the help of advanced analytics, pharma companies can intelligently search vast data sets of patients, clinical trial data, and drug distribution to help accelerate the discovery of new drugs and increase work processes. Many of today’s analytical service companies are equipped with advanced high-resolution accurate mass spectrometry (HRAM) instruments, which eliminate the need to perform multiple trials and increase the reliability of operations. Besides, the analysis of the available data like patient demography or genetic identity enables pharma companies to speed up the diagnosis of diseases and design more efficient control groups.
Moreover, by integrating analytical strategies into their workflow, organisations can streamline their sales and marketing outreach. The insights gained from available data enable pharma companies to identify and augment their marketing channels while paving way into newer customer pools.
Furthermore, today, outsourcing analytical services has become the preferred option for most pharma companies as it helps them focus on their core competencies and allows them to share intricate tasks with third-party service providers.
As a multitude of these trends is set to nurture the pharmaceutical industry’s growth, Pharma Tech Outlook Europe has compiled a list of leading analytical services providers in the European region that are at the top of their game. The enlisted organisations are transforming the analytical services at the convergence of several disruptive technologies. Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for aspiring CIOs and CXOs.
We present to you Pharma Tech Outlook Europe’s “Top 10 Analytical Services Providers in Europe – 2021.”
